NASDAQ:ISO

IsoPlexis (ISO) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $0.76
▼
$0.76
50-Day Range: $0.74
▼
$1.13
52-Week Range: $0.60
▼
$5.10

Volume: N/A
Average Volume: 68,375 shs
Market Capitalization: $30.28 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.60

About IsoPlexis (NASDAQ:ISO) Stock

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

ISO Stock News Headlines

May 16, 2023 | marketwatch.com

10-Q: PHENOMEX INC.

May 12, 2023 | finanznachrichten.de

PhenomeX Reports First Quarter 2023 Financial Results

June 10, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Software" to Revolutionize Warfare

This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>

May 5, 2023 | marketwatch.com

Single Cell Proteomics System Market Insights, Forecast to 2029 Market Size 2023-2031 Industrial Regions by Absolute Reports | with [90 Pages]

May 3, 2023 | marketwatch.com

Single Cell Proteomics Analysis System Market Insights, Forecast to 2029 Market Size and volume sale report 2023

April 14, 2023 | marketwatch.com

Tabula Rasa HealthCare Removes Interim Tag, Names Brian Adams CEO

April 13, 2023 | americanbankingnews.com

Contrasting IsoPlexis (ISO) and Its Competitors

April 11, 2023 | americanbankingnews.com

IsoPlexis (ISO) & Its Competitors Critical Contrast

June 10, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Software" to Revolutionize Warfare

April 8, 2023 | americanbankingnews.com

IsoPlexis (ISO) and Its Peers Head to Head Review

April 2, 2023 | americanbankingnews.com

Critical Survey: IsoPlexis (ISO) vs. Its Peers

March 26, 2023 | americanbankingnews.com

Contrasting IsoPlexis (ISO) and The Competition

March 23, 2023 | americanbankingnews.com

Analyzing IsoPlexis (ISO) and The Competition

March 23, 2023 | americanbankingnews.com

IsoPlexis (ISO) and Its Competitors Head-To-Head Analysis

March 21, 2023 | finance.yahoo.com

PhenomeX Strengthens Commercial Leadership Team

March 21, 2023 | americanbankingnews.com

Contrasting Harvard Bioscience (NASDAQ:HBIO) and IsoPlexis (NASDAQ:ISO)

February 18, 2023 | finance.yahoo.com

IsoPlexis Corporation (ISO) Stock Historical Prices & Data - Yahoo Finance

February 9, 2023 | finance.yahoo.com

IsoPlexis Corporation's (NASDAQ:ISO) recent US$6.3m market cap decline means a loss of US$65k for insiders who bought this year

February 4, 2023 | benzinga.com

SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation

January 15, 2023 | finanznachrichten.de

IsoPlexis Corporation: Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

January 12, 2023 | benzinga.com

IsoPlexis Granted U.S. Patent Titled 'METHODS OF USING NUCLEOTIDE ANALOGUES'

January 12, 2023 | msn.com

IsoPlexis expects FY22 revenue to be below consensus

January 12, 2023 | finance.yahoo.com

IsoPlexis Reports Preliminary Full Year 2022 Revenue

January 10, 2023 | msn.com

Berkeley Lights' Preliminary 2022 Results Deficient, Analysts Say All Eyes On IsoPlexis Execution

January 5, 2023 | msn.com

Morgan Stanley Maintains Equal-Weight Rating for IsoPlexis: Here's What You Need To Know

December 23, 2022 | barrons.com

Thinking about buying stock in Mullen Automotive, Cleveland-Cliffs, CarMax, IsoPlexis, or Teva Pharmaceutical?

December 23, 2022 | markets.businessinsider.com

Analysts Conflicted on These Technology Names: Workday (WDAY) and IsoPlexis (ISO)

See More Headlines

ISO Company Calendar

Last Earnings: 11/10/2021
Today: 6/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ISO
CUSIP: N/A
CIK: 1615055
Web: isoplexis.com
Phone: 203-208-4111
Fax: N/A
Employees: 459
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $1.60
High Stock Price Forecast: $1.70
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +110.1%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.70)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-106,000,000.00
Net Margins: -632.41%
Pretax Margin: -632.40%
Return on Equity: -127.86%
Return on Assets: -71.41%

Debt

Debt-to-Equity Ratio: 1.12
Current Ratio: 4.06
Quick Ratio: 2.50

Sales & Book Value

Annual Sales: $16.76 million
Price / Sales: 1.81
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.04 per share
Price / Book: 0.73

Miscellaneous

Outstanding Shares: 39,760,000
Free Float: 37,218,000
Market Cap: $30.28 million
Optionable: Not Optionable
Beta: 1.32

Key Executives

Mr. Sean Mackay (Age 40)
Co-Founder, CEO, Pres & Director
Comp: $635.55k

Mr. John R. Strahley CPA (Age 55)
Chief Financial Officer
Comp: $444.11k

Mr. Rong Fan
Co-Founder & Chairman of Scientific Advisory Board

Mr. Jon Chen
VP of Scientific Alliance Technology & Co-Founder

Mr. Anthony Catalano
Sr. VP of Operations

Mr. Rajesh T. Khakhar
VP of Fin. & Principal Accounting Officer

Ms. Jing Zhou M.D. (Age 52)
Ph.D., Chief Scientific Officer

Mr. Richard W. Rew II (Age 54)
Sr. VP, Gen. Counsel & Sec.

Ms. Verna Siu
Sr. VP of Sales Operations

Ms. Carrie Carter
Sr. VP of People Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ISO Stock - Frequently Asked Questions

Should I buy or sell IsoPlexis stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IsoPlexis in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ISO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ISO, but not buy additional shares or sell existing shares.
View ISO analyst ratings or view top-rated stocks.
What is IsoPlexis' stock price forecast for 2023?: 2 Wall Street research analysts have issued 12-month price objectives for IsoPlexis' stock. Their ISO share price forecasts range from $1.50 to $1.70. On average, they expect the company's stock price to reach $1.60 in the next twelve months. This suggests a possible upside of 110.1% from the stock's current price.
View analysts price targets for ISO or view top-rated stocks among Wall Street analysts.
How were IsoPlexis' earnings last quarter?: IsoPlexis Co. (NASDAQ:ISO) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($10.66) EPS for the quarter, missing analysts' consensus estimates of ($0.79) by $9.87. The company had revenue of $4.19 million for the quarter, compared to the consensus estimate of $3.79 million. IsoPlexis had a negative net margin of 632.41% and a negative trailing twelve-month return on equity of 127.86%.
When did IsoPlexis IPO?: (ISO) raised $125 million in an initial public offering on Friday, October 8th 2021. The company issued 8,333,000 shares at $14.00-$16.00 per share.

What is IsoPlexis' stock symbol?: IsoPlexis trades on the NASDAQ under the ticker symbol "ISO."
What is IsoPlexis' stock price today?: One share of ISO stock can currently be purchased for approximately $0.76.
How much money does IsoPlexis make?: IsoPlexis (NASDAQ:ISO) has a market capitalization of $30.28 million and generates $16.76 million in revenue each year. The company earns $-106,000,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis.
How many employees does IsoPlexis have?: The company employs 459 workers across the globe.
How can I contact IsoPlexis?: IsoPlexis' mailing address is 35 NE INDUSTRIAL ROAD, BRANFORD CT, 06405. The official website for the company is isoplexis.com. The company can be reached via phone at 203-208-4111 or via email at investors@isoplexis.com.

This page (NASDAQ:ISO) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

IsoPlexis (ISO) Stock Forecast, Price & News

About IsoPlexis (NASDAQ:ISO) Stock

ISO Stock News Headlines

ISO Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

ISO Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info